245 related articles for article (PubMed ID: 9560832)
1. Low molecular weight heparins: the future of thromboembolic therapy.
Dobbin KR
Nurse Pract; 1998 Mar; 23(3):98,101-4,106-7. PubMed ID: 9560832
[No Abstract] [Full Text] [Related]
2. [Thrombophilia, thromboembolism and the use of the unfractionated and low-molecular-weight heparins].
Lobato-Mendizábal E; Majluf-Cruz A
Rev Invest Clin; 2000; 52(5):529-45. PubMed ID: 11195182
[TBL] [Abstract][Full Text] [Related]
3. The status of new anticoagulants.
Bates SM; Weitz JI
Br J Haematol; 2006 Jul; 134(1):3-19. PubMed ID: 16803562
[TBL] [Abstract][Full Text] [Related]
4. Dalteparin: pharmacological properties and clinical efficacy in the prophylaxis and treatment of thromboembolic diseases.
Pineo GF; Hull RD
Eur J Med Res; 2004 Apr; 9(4):215-24. PubMed ID: 15210402
[TBL] [Abstract][Full Text] [Related]
5. [Low-molecular-weight heparins].
Ostermann H
Internist (Berl); 1998 Apr; 39(4):414-5. PubMed ID: 9599756
[No Abstract] [Full Text] [Related]
6. Anticoagulants and cancer survival.
Piccioli A; Falanga A; Prandoni P
Semin Thromb Hemost; 2006 Nov; 32(8):810-3. PubMed ID: 17171594
[TBL] [Abstract][Full Text] [Related]
7. [Anticoagulation with low molecular weight heparins within the framework of cardioversion for atrial fibrillation].
Tebbe U
Dtsch Med Wochenschr; 2007 Sep; 132(39):2033-6. PubMed ID: 17882745
[No Abstract] [Full Text] [Related]
8. [Prevention of postoperative venous thromboembolic complications].
Savel'ev VS; Gologorskiĭ VA; Kirienko AI; Gel'fand BR
Anesteziol Reanimatol; 2000; (4):68-71. PubMed ID: 11014003
[TBL] [Abstract][Full Text] [Related]
9. [Heparin and cancer].
Lykke J
Ugeskr Laeger; 2006 Dec; 168(50):4397-401. PubMed ID: 17217864
[TBL] [Abstract][Full Text] [Related]
10. [Heparins, antivitamins K. Principles and rules of use. Posology of non-fractionated heparins].
Delsart D; Chambefort V; Decousus H
Rev Prat; 2001 Sep; 51(13):1489-97. PubMed ID: 11601082
[No Abstract] [Full Text] [Related]
11. Old and new heparins.
Cosmi B; Palareti G
Thromb Res; 2012 Mar; 129(3):388-91. PubMed ID: 22137740
[TBL] [Abstract][Full Text] [Related]
12. Anticoagulant therapy in pregnant women with mechanical heart valves.
Leyh RT; Fischer S; Ruhparwar A; Haverich A
Arch Gynecol Obstet; 2003 Apr; 268(1):1-4. PubMed ID: 12673466
[TBL] [Abstract][Full Text] [Related]
13. Low-molecular-weight heparin in oncology.
Zacharski LR; Loynes JT
Anticancer Res; 2003; 23(3C):2789-93. PubMed ID: 12926114
[TBL] [Abstract][Full Text] [Related]
14. Venous thromboembolism and cancer: prevention and therapy.
Lee AY
Vnitr Lek; 2006 Mar; 52 Suppl 1():127-8, 130-1. PubMed ID: 16637461
[TBL] [Abstract][Full Text] [Related]
15. Management of thromboembolism in pregnancy.
Marks PW
Semin Perinatol; 2007 Aug; 31(4):227-31. PubMed ID: 17825678
[TBL] [Abstract][Full Text] [Related]
16. Effects of anticoagulants on cancer: heparins.
Pineo GF; Hull RD
Cancer Treat Res; 2009; 148():259-75. PubMed ID: 19377929
[No Abstract] [Full Text] [Related]
17. Recurrent thromboembolism in ovarian cancer.
Fuglsang J; Ingerslev J; Havsteen H
Acta Obstet Gynecol Scand; 2004 Dec; 83(12):1218-20. PubMed ID: 15548160
[No Abstract] [Full Text] [Related]
18. [Low-molecular heparin in doses adapted to body weight. Management of thromboembolic diseases].
Internist (Berl); 1999 May; 40(5 Suppl Management):1-16. PubMed ID: 10367262
[No Abstract] [Full Text] [Related]
19. [Low-molecular-weight heparin - enoxaparin (clexane) in the prevention of thromboembolic complications in surgical patients].
Zabolotskikh IB; Sin'kov SV; Klevko VA
Anesteziol Reanimatol; 2001; (2):70-5. PubMed ID: 11494909
[No Abstract] [Full Text] [Related]
20. Thromboembolism in pregnancy: an overview.
Girling JC; de Swiet M
Curr Opin Obstet Gynecol; 1996 Dec; 8(6):458-63. PubMed ID: 8979019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
